EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas

Aglaya G Iyevleva iD, Svetlana N Aleksakhina iD, Anna P Sokolenko iD, Ekaterina A Otradnova, Alisa S Nikitina, Kira A Kashko iD, Maria V Syomina iD, Anna D Shestakova, Ekaterina S Kuligina iD, Natalia S Morozova iD, Sergey V Popov, Pavel V Vyazovcev und 29 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262411851 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Aglaya G Iyevleva und 40 weiteren Autor:innen. Beteiligte Einrichtung: N.N. Petrov Institute of Oncology, Saint-Petersburg 197758, Russia. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Recombinational DNA Repair, Mutation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homologous recombination deficiency (HRD) resulting from inactivation of BRCA1/2 genes promotes chromosomal instability and renders tumor cells susceptible to platinum derivatives and PARP inhibitors (PARPi). The contribution of alterations in other homologous recombination repair (HRR) genes to HRD remains understudied. This investigation aimed to analyze the spectrum of mutations in 34 HRR genes in prostate carcinomas (PCs) and study the relationship between HRR status and HRD. HRR mutations and HRD scores were examined by NGS in 1131 and 680 PCs, respectively. Pathogenic or likely pathogenic variants in HRR genes were detected in 216/1131 cases (19.1%). HRD, defined by an HRD score cut-off of ≥42, was observed more frequently in HRR-mutated than in wild-type tumors (23/120 (19.2%) vs. 29/560 (5.2%), p < 0.0001). The highest HRD scores were detected in PCs with biallelic inactivation of the BRCA2 or PALB2 genes, as well as in tumors with BRIP1 mutations. HRD was also occasionally seen in PCs with ATM, NBN, FANCM, BRCA1 and CDK12 alterations, but never in cases with CHEK2 mutations. HRD was significantly more associated with aggressive PC features than HRR mutations. The majority of CDK12-mutated tumors exhibited a distinct type of copy number variations (CNV)–a tandem duplication phenotype. Our study suggests that the selection of PC patients for PARPi treatment requires a significant revision of existing attitudes towards tumor genetic profiling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRecombinational DNA RepairMutationHumansMaleMiddle AgedAgedBRCA2 ProteinFanconi Anemia Complementation Group N ProteinBRCA1 ProteinHomologous Recombination

Stichwörter der Autor:innen

HRD scorehomologous recombination deficiencymutations in homologous recombination repair genesprostate cancer

Substanzen

BRCA2 ProteinBRCA2 protein, humanFanconi Anemia Complementation Group N ProteinBRCA1 Protein

Autor:innen und Institutionen

  • N.N. Petrov Institute of Oncology, Saint-Petersburg 197758, Russia.
  • Department of Medical Genetics, Saint Petersburg State Pediatric Medical University, Saint Petersburg 194100, Russia.
  • Saint Luke's Clinical Hospital, Saint Petersburg 194044, Russia.
  • Saint Petersburg City Oncological Clinic, Saint-Petersburg 197022, Russia.
  • Stavropol Regional Oncological Clinic, Stavropol 355047, Russia.
  • Tula Regional Oncological Clinic, Tula 300039, Russia.

ORCID-Profile: Aglaya G Iyevleva, Svetlana N Aleksakhina, Anna P Sokolenko, Kira A Kashko, Maria V Syomina, Ekaterina S Kuligina, Natalia S Morozova, Marina N Nechaeva, Evgeny N Imyanitov

Förderung

  • Russian Science Foundation

Zitieren

APA

Iyevleva, A. G., Aleksakhina, S. N., Sokolenko, A. P., Otradnova, E. A., Nikitina, A. S., Kashko, K. A., Syomina, M. V., Shestakova, A. D., Kuligina, E. S., Morozova, N. S., Popov, S. V., Vyazovcev, P. V., Luchkova, T. Y., Peremyshlenko, A. S., Topuzov, T. M., Gudkova, O. M., Orlova, R. V., Levushkin, A. V., Moiseev, D. O., …, & Imyanitov, E. N. (2025). Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411851

Vancouver

Iyevleva AG, Aleksakhina SN, Sokolenko AP, Otradnova EA, Nikitina AS, Kashko KA, et al. Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411851

BibTeX
@article{Iyevleva2025,
  author = {Iyevleva, Aglaya G and Aleksakhina, Svetlana N and Sokolenko, Anna P and Otradnova, Ekaterina A and Nikitina, Alisa S and Kashko, Kira A and Syomina, Maria V and Shestakova, Anna D and Kuligina, Ekaterina S and Morozova, Natalia S and Popov, Sergey V and Vyazovcev, Pavel V and Luchkova, Tatyana Y and Peremyshlenko, Aleksey S and Topuzov, Timur M and Gudkova, Olga M and Orlova, Rashida V and Levushkin, Andrey V and Moiseev, Daniil O and Shkodenko, Oksana N and Gubarev, Demyan V and Dzyuba, Aleksandr V and Povorina, Irina Y and Agaeva, Anna V and Kutyan, Vladislav F and Grigoryan, Mhitar M and Orlov, Alexey N and Lefterov, Spartak I and Belousov, Aleksey V and Nechaeva, Marina N and Vorobyeva, Elena N and Amirkhanova, Irina K and Kryukova, Nadezhda V and Zatulivetrova, Lyubov I and Gomboeva, Aryuna B and Krivtsov, Vladimir N and Shchiglik, Olga I and Prokudina, Natalya V and Butunina, Natalya A and Belyaev, Aleksey M and Imyanitov, Evgeny N},
  title = {Complex Relationships Between Homologous Recombination Deficiency (HRD) Score and Mutational Status of Homologous Recombination Repair (HRR) Genes in Prostate Carcinomas},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262411851}
}
Kostenlos starten →